Entries by Sarah Abelsohn

Interview with Bright Minds Biosciences’ CEO Ian McDonald

In today’s episode of the Psychedelic Spotlight podcast, the Psychedelic Investor, James Hallifax interviews Ian McDonald, CEO and Director of Bright Minds Biosciences. For any investors out there, you can find Bright Minds Biosciences trading on the Canadian Securities Exchange under the symbol $DRUG and on the American OTC market under the symbol $BMBIF. In […]

Why the Psychedelic Drug Market is Experiencing Major Growth

David Flores, CEO of Global Trac Solutions (PSYC), joins Cheddar to discuss the company’s digital media platform ‘Psychedelic Spotlight’, factors contributing to a more open-minded approach to psychedelics among the scientific and medical communities, and why investors are seeing the psychedelic market as an opportunity for growth. #business #psychedelics #investments source

Psychedelic Spotlight Interview with Douglas K. Gordon

In this episode of the Psychedelic Spotlight podcast, we connect with Douglas K. Gordon, CEO of Silo Wellness, a wellness company in the psychedelics and functional mushroom marketplace. In our conversation with Douglas, we discuss the company’s collaboration with the Bob Marley Estate, and their recent expansion to the Frankfurt Exchange. *To learn more about […]

Psychedelic Spotlight Interview with Rabbi Zac Kamenetz

In this episode of the Psychedelic Spotlight podcast, we speak with Rabbi Zac Kamenetz, the Founder, and CEO of Shefa and the Co-Founder of the Jewish Psychedelic Summit. In our conversation with Rabbi Zac, we discussed the forthcoming Jewish Psychedelic Summit, which kicks off on May 2, 2021, and which, in addition to himself, is […]

Psychedelic Spotlight Interview with Joshua White

In this episode of the Psychedelic Spotlight podcast, we speak with Joshua White, the Co-Founder and Director of Fireside Project, the first Psychedelic Peer Support Line. Joshua speaks about the creation of the Fireside Project and the future of the organization. *To learn more about the company featured in this episode and the work they’re […]

Psychedelic Spotlight Interview with Pierre Bouchard

In this episode of the Psychedelic Spotlight podcast, we speak with Pierre Bouchard, a psychotherapist from Boulder, CO. Pierre talks about the delivery of ketamine therapy and what patients can expect going into a session. *Get the latest industry news around all things psychedelics by visiting our website, and be sure to subscribe to our […]

Psychedelic Spotlight Interview with Timothy Ko

In this episode of the Psychedelic Spotlight podcast, we spend some time with Timothy Ko who is the CEO of Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) (FSE: “1XU1”), a biotechnology company focused on developing psychedelic medicines to treat addiction. In our conversation with Mr. Ko, we discuss how the company plans to utilize the psychedelic […]

Psychedelic Spotlight Interview with David Champion

In this episode of the Psychedelic Spotlight podcast, we speak with David Champion who is the Co-Founder and CEO of Maya Health, a company dedicated to empowering psychedelic practitioners with the technology and insight they need to scale psychedelic healthcare safely and effectively. In our conversation with David, we learn how Maya Health is leveraging […]

HAVN Life Sciences Update

HAVN Life Sciences Inc. CEO, Tim Moore, updates the recent launch of its new line of natural health products and more. *To learn more about the company featured in this video and the work they’re doing, visit their website: https://havnlife.com and https://yourhavnlife.com *Get the latest industry news around all things psychedelics by visiting our website, […]